ALX Oncology Holdings Inc. Common Stock (ALXO) Stock Price, Quote & AI Analysis
Live ALXO stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for ALX Oncology Holdings Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for ALX Oncology Holdings Inc. Common Stock (ALXO), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
ALX Oncology Holdings Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
ALX Oncology Holdings Inc. Common Stock Overview
Company information
Company Overview
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
ALX Oncology Holdings Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...